SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation

NCT03230747 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitral Regurgitation
Mitral Disease

Interventions

DEVICE: Edwards SAPIEN M3 System

Sponsor

Edwards Lifesciences